Badger Infrastructure Solutions Ltd. (TSX:BDGI)

CTI BioPharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	777.39	744.95	683.8	570.81	453.91	438.41
Revenue Growth (YoY)	8.41%	8.94%	19.79%	25.75%	3.54%	-13.09%
Cost of Revenue	546.42	526.95	492.71	431.66	361.06	314.07
Gross Profit	230.97	218.01	191.09	139.15	92.85	124.34
Selling, General & Admin	42.2	41.93	40.79	39.19	36.96	31.09
Operating Expenses	141.11	131.95	128.83	104.29	96.54	95.19
Operating Income	89.86	86.06	62.27	34.87	-3.69	29.15
Interest Expense	-14.66	-14.58	-16.11	-7.56	-4.41	-6.54
Currency Exchange Gain (Loss)	-0.2	-0.07	-0.33	-0.36	0.07	1.66
Other Non Operating Income (Expenses)	2.71	-5.7	9.24	-4.39	-2.14	-
EBT Excluding Unusual Items	77.71	65.71	55.07	22.55	-10.17	24.27
Merger & Restructuring Charges	-	-	-	-	-2.13	-3.62
Gain (Loss) on Sale of Assets	1.11	1.76	2.05	0.33	-1.37	-1.41
Other Unusual Items	-	-	-	-	2.4	6.77
Pretax Income	78.83	67.47	57.12	22.88	-11.27	26.01
Income Tax Expense	22.89	19.6	15.35	4.59	-2.54	6.59
Net Income	55.94	47.87	41.77	18.29	-8.74	19.42
Net Income to Common	55.94	47.87	41.77	18.29	-8.74	19.42
Net Income Growth	34.21%	14.61%	128.38%	-	-	-57.82%
Shares Outstanding (Basic)	34	34	34	34	35	35
Shares Outstanding (Diluted)	34	34	34	34	35	35
Shares Change (YoY)	-0.90%	-0.09%	-	-0.37%	-0.78%	-2.67%
EPS (Basic)	1.64	1.39	1.21	0.53	-0.25	0.56
EPS (Diluted)	1.64	1.39	1.21	0.53	-0.25	0.56
EPS Growth	35.62%	14.87%	128.30%	-	-	-56.67%
Free Cash Flow	58.87	48.28	24.62	3.12	11.82	63.97
Free Cash Flow Per Share	1.72	1.40	0.71	0.09	0.34	1.83
Dividend Per Share	0.512	0.500	0.522	0.488	0.494	0.467
Dividend Growth	-2.27%	-4.23%	7.14%	-1.26%	5.76%	7.20%
Gross Margin	29.71%	29.27%	27.95%	24.38%	20.46%	28.36%
Operating Margin	11.56%	11.55%	9.11%	6.11%	-0.81%	6.65%
Profit Margin	7.20%	6.43%	6.11%	3.20%	-1.93%	4.43%
Free Cash Flow Margin	7.57%	6.48%	3.60%	0.55%	2.60%	14.59%
EBITDA	140.07	143.05	115.37	83.02	44.51	78.18
EBITDA Margin	18.02%	19.20%	16.87%	14.54%	9.80%	17.83%
D&A For EBITDA	50.21	56.99	53.1	48.15	48.2	49.03
EBIT	89.86	86.06	62.27	34.87	-3.69	29.15
EBIT Margin	11.56%	11.55%	9.11%	6.11%	-0.81%	6.65%
Effective Tax Rate	29.03%	29.04%	26.88%	20.07%	-	25.33%

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.